Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Frndcal is a line of combination dietary supplements developed by Primus Remedies, designed to support bone, joint, and cardiovascular health. The formulations, which include Frndcal M+ and Frndcal K2 Strong, typically contain essential bone-supporting nutrients such as calcium (in forms like calcium citrate malate or calcium carbonate), vitamin D3 (cholecalciferol or calcitriol), magnesium, zinc, vitamin K2-7 (menaquinone-7), vitamin B12 (cyanocobalamin), and L-methylfolate. These ingredients work synergistically to enhance calcium absorption, promote bone mineralization, maintain bone density, and support muscle and cardiovascular function by preventing arterial calcification.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Frndcal.